A2 Biotherapeutics scores $71.5m Series B
Agoura Hills, California-based A2 Biotherapeutics, a developer of cell therapies for solid tumor cancer patients, has raised $71.5 million in Series B financing.
Agoura Hills, California-based A2 Biotherapeutics, a developer of cell therapies for solid tumor cancer patients, has raised $71.5 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination